Vinflunine plus capecitabine for advanced breast cancer previously treated with or resistant to anthracycline and resistant to taxane: A phase III study versus capecitabine.-Reference-Cited by-同舟云学术

Vinflunine plus capecitabine for advanced breast cancer previously treated with or resistant to anthracycline and resistant to taxane: A phase III study versus capecitabine.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:1013-1013
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Aapro Matti S.¹,Demidchik Yuri²,Bondarenko Igor³,Siedakov Igor⁴,Sakaeva Dina⁵,Krishnamurthy S.⁶,Roman Laslo⁷,Lebedeva Liudmila⁸,Mefti Fawzia⁹,Ponomarova Olga¹⁰,Bachelot Thomas Denis¹¹,Lytvyn Iryna¹²,Delaloge Suzette¹³,Kupp Anita¹⁴,Karchmit Yauheniya¹⁵,Bougnoux Philippe¹⁶,Campone Mario¹⁷,Martin Miguel¹⁸

Affiliation:

1. Clinique de Genolier, Genolier, Switzerland

2. Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus

3. Dnipropetrovsk City Multi-Field Clinical Hospital #4, Dnipropetrovsk, Ukraine

4. Regional Antitumor Center, Donetsk, Ukraine

5. Republican Clinical Oncology Dispensary, Ufa, Russia

6. Kidway Memorial Institute of Oncology, Bangalore, India

7. Leningrad Regional Oncology Dispensary, St. Petersburg, Russia

8. Clinical Oncology Dispensary, Arkhangelsk, Russia

9. Hôpital René Huguenin/Institut Curie, Saint-Cloud, France

10. City Oncology Hospital, Kiev, Ukraine

11. Département d'Oncologie Médicale, Centre Léon Berard, Lyon, France

12. Regional Oncology Hospital, Dnipropetrovsk, Ukraine

13. Institut de Cancerologie Gustave Roussy, Villejuif, France

14. North Estonia Medical Center, Tallinn, Estonia

15. Regional Clinical Oncology Dispensary, Vitebsk, Belarus

16. Department of Medical Oncology, CHU Bretonneau, Tours, France

17. Institut de Cancérologie de l'Ouest, Nantes, France

18. Hospital Universitario Gregorio Maranon, Madrid, Spain

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.1013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer;Critical Reviews in Oncology/Hematology;2016-04